Literature DB >> 15356025

The skeletal phenotype of men with previous constitutional delay of puberty.

Fabian Yap1, Wolfgang Högler, Julie Briody, Bin Moore, Robert Howman-Giles, Christopher T Cowell.   

Abstract

It is presently unclear whether men with a history of constitutional delay (CD) of puberty are osteopenic. This study compares auxology, bone mass, size, and density of 32 men (age, 21-33 yr) with previous CD with 45 controls. Using dual-energy x-ray absorptiometry, areal bone mineral density (aBMD) and volumetric bone mineral density at the lumbar spine (LS) and femoral neck (FN), hip strength analysis, and total-body and body segment (arms, legs, trunk) measurements were determined. Auxological variables, body composition, the muscle-bone relation, and the effect of prior androgen treatment were studied. Men with previous CD were shorter (P < 0.001) and had shorter height-adjusted arms compared with controls. Height-adjusted total-body bone mineral content (BMC) (P = 0.004), aBMD (P = 0.016), and bone area (P = 0.006) but not lean tissue mass (P = 0.507) were lower in CD men compared with controls; consequently, their BMC to lean tissue mass ratio was reduced (P < 0.001). Segment length-adjusted BMC and bone area of arms (P < 0.001) and legs (P < 0.03), but not trunk were lower in CD men than in controls. They had lower LS aBMD (P = 0.044) but normal LS and FN volumetric bone mineral density. Size-adjusted LS width and the hip cross-sectional area were lower than in controls. There was no difference in anthropometric or dual-energy x-ray absorptiometry results between untreated (n = 15) and androgen-treated (n = 17) CD men.We conclude that men with previous CD have normal LS and FN volumetric density but reduced total-body bone mass, which was explained by reduced limb bone mass and size. Together with the reduced LS bone width and hip crosssectional area, these skeletal characteristics suggest impaired periosteal expansion during puberty. The skeletal phenotype of CD males may be altered by their late onset of puberty.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356025     DOI: 10.1210/jc.2004-0046

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Effects of the Timing of Sex-Steroid Exposure in Adolescence on Adult Health Outcomes.

Authors:  Yee-Ming Chan; Amalia Feld; Elfa Jonsdottir-Lewis
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

2.  Effects of growth hormone and nutritional therapy in boys with constitutional growth delay: a randomized controlled trial.

Authors:  Joan C Han; Ligeia Damaso; Susan Welch; Prabhakaran Balagopal; Jobayer Hossain; Nelly Mauras
Journal:  J Pediatr       Date:  2010-10-18       Impact factor: 4.406

3.  Age at onset of puberty predicts bone mass in young adulthood.

Authors:  Vicente Gilsanz; James Chalfant; Heidi Kalkwarf; Babette Zemel; Joan Lappe; Sharon Oberfield; John Shepherd; Tishya Wren; Karen Winer
Journal:  J Pediatr       Date:  2010-08-24       Impact factor: 4.406

Review 4.  Impact of gender-affirming treatment on bone health in transgender and gender diverse youth.

Authors:  Silvia Ciancia; Vanessa Dubois; Martine Cools
Journal:  Endocr Connect       Date:  2022-09-28       Impact factor: 3.221

5.  Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton.

Authors:  Kristine M Wiren; Anthony A Semirale; Xiao-Wei Zhang; Adrian Woo; Steven M Tommasini; Christopher Price; Mitchell B Schaffler; Karl J Jepsen
Journal:  Bone       Date:  2008-05-16       Impact factor: 4.398

Review 6.  Testosterone Use in Adolescent Males: Current Practice and Unmet Needs.

Authors:  Maria Vogiatzi; James P Tursi; Jonathan S Jaffe; Sue Hobson; Alan D Rogol
Journal:  J Endocr Soc       Date:  2020-10-30

Review 7.  Adult Consequences of Self-Limited Delayed Puberty.

Authors:  Jia Zhu; Yee-Ming Chan
Journal:  Pediatrics       Date:  2017-05-18       Impact factor: 7.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.